Content area
Full text
Pioneered by research into Electrical Impedance Spectroscopy (EIS) at the University of Sheffield, the device was brought to market by a UK- based company EveryBaby
A new medical device that improves the prediction of pre-term birth at a fraction of the cost of current methods, will help to reduce the global number of deaths and long-term complications caused by babies born prematurely.
Pioneering research carried out on Electrical Impedance Spectroscopy (EIS) at the University of Sheffield has led to the creation of the device, brought to market by EveryBaby, a UK-based company backed by South Korean investment.
Current technologies for assessing the likelihood of pre-term birth, such as transvaginal ultrasound, are expensive and not always available, especially in poorer countries.




